Combination therapy with gemcitabine and docetaxel is effective in patients with advanced urothelial cancer

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1416, 2003-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

BA11: Randomised Phase III Study Comparing Paclitaxel/Cisplatin/Gemcitabine and Cisplatin/Gemcitabine in Patients with Metastatic or Locally Advanced Urothelial Cancer without Prior Systemic Therapy*

By  

UroOncology, Vol. 2, Iss. 2, 2002-01 ,pp. : 55-56

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Gemcitabine/epirubicin/docetaxel effective in early breast cancer

By  

Inpharma, Vol. 1, Iss. 1471, 2005-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Gemcitabine plus docetaxel `has moderate activity' in advanced pancreatic cancer

By  

Inpharma, Vol. 1, Iss. 1281, 2001-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Docetaxel plus gemcitabine shows antitumour efficacy in patients with advanced NSCLC

By  

Inpharma, Vol. 1, Iss. 1280, 2001-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Docetaxel/trastuzumab combination therapy for the treatment of breast cancer

By Nabholtz Jean-marc   Gligorov Joseph  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1555-1564

Informa Healthcare

Access to resources Recommend Favorite